WeVote
Log In

Bill

Bill

SB 1711

AHCCCS; obesity treatment; study committee

57th Legislature - First Regular Session Introduced by David Gowan

Arizona establishes study committee to evaluate obesity treatment coverage options and access barriers within AHCCCS health program for low-income residents.

Signed by Governor
0
WeVote Research Nonpartisan
Bill Summary · SB 1711

Legislative bill overview

SB 1711 establishes a study committee in Arizona to examine obesity treatment coverage and access through the state's AHCCCS (Arizona Health Care Cost Containment System) program. The committee will analyze current policies, barriers to treatment, and make recommendations for potential legislative or administrative changes regarding obesity care coverage.

Why is this important

Obesity affects a significant portion of Arizona's population and carries substantial public health and healthcare cost implications. The study could influence whether AHCCCS—which serves low-income Arizonans—expands coverage for obesity treatments including medications, surgeries, and behavioral interventions, potentially affecting hundreds of thousands of beneficiaries and state healthcare spending.

Potential points of contention

  • Cost implications: Expanded obesity treatment coverage could increase AHCCCS expenditures, raising questions about budget sustainability and competing healthcare priorities
  • Medication access debate: Recommendations may address expensive GLP-1 drugs (like Ozempic/Wegovy), creating tension between pharmaceutical access advocates and fiscal conservatives concerned about state costs
  • Definition and scope: Disagreement may arise over what counts as "obesity treatment" and whether coverage should include preventive vs. clinical interventions, and behavioral health services

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.